Spasticity Market: Industry Analysis, Epidemiology, Pipeline Therapies, Treatment and Companies by DelveInsight| Osmotica Pharmaceuticals, Revance Therapeutics, Bionorica SE and Others.
Spasticity is defined as “sensorimotor disorder characterized by a velocity-dependent increase in tonic stretch reflexes with exaggerated tendon jerks, resulting from hyperexcitability of the stretch reflex” or from an upper motor neuron lesion (UMN), presenting as an intermittent or sustained involuntary activations of muscles. The region and the extent of impairment depend on the area of the brain or spinal cord that has been damaged. It can occur in the upper and/or lower limbs.
DelveInsight's " Spasticity
Market Insights, Epidemiology, and Market Forecast-2030" report
delivers an in-depth understanding of the Spasticity, historical and forecasted
epidemiology as well as the Spasticity market trends in the United States, EU5
(Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Key Highlights
from the Spasticity
Market Report:
·
In the US, about 764,000 children and adults
currently have Cerebral Palsy and around 500,000 children under age of 18
currently have Cerebral Palsy.
·
In UK the prevalence of CP is 186 per 100,000
population, such that a total of 110,000 people are affected.
·
Spasticity affects approximately 35% of those
with stroke, more than 90% with CP, about 50% of Traumatic brain injury (TBI)
patients, 40% of SCI patients, and between 37% and 78% of MS patients.
·
According to DelveInsight’s analysis, Children
are affected more with Spasticity as compared to adult.
·
United States has the highest percentage of
Prevalent diagnosed & treated patients
View Report: https://www.delveinsight.com/report-store/spasticity-market
To gain more insights
request sample @ https://www.delveinsight.com/report-store/spasticity-market
Spasticity
is the most commonly reported symptom for Multiple sclerosis, seen in 90% of
patients. Most cases of spasticity can be subdivided into spinal or cerebral
spasticity. Spinal spasticity results from the removal or destruction of
supraspinal control and leads to increased excitability of motor neurons,
whereas cerebral spasticity stems from a loss of descending inhibition.
The American Association of Neurological Surgeons estimated
that spasticity affects more than 12 million people worldwide.
View Report: https://www.delveinsight.com/report-store/spasticity-market
To gain more insights
request sample @ https://www.delveinsight.com/report-store/spasticity-market
Some of the Spasticity
Companies:
- Osmotica
Pharmaceuticals,
- Revance
Therapeutics
- Bionorica
SE
- Merz
Pharmaceuticals
- GW
Pharmaceuticals Ltd.
- And
Many Others
Spasticity
Pipeline Therapies:
- Arbaclofen
ER
- DAXI
- BX-1
- And
Many Others
View Report: https://www.delveinsight.com/report-store/spasticity-market
To gain more insights
request sample @ https://www.delveinsight.com/report-store/spasticity-market
Table of Contents
1. |
Report Introduction |
2. |
Executive Summary of Spasticity |
3. |
Spasticity Market Overview at a Glance |
4. |
Disease Background and Overview: Spasticity |
5. |
Case Reports of Spasticity |
6. |
Spasticity Patient Journey |
7. |
Spasticity Epidemiology and Patient Population |
8. |
Epidemiology of Spasticity by Countries (2018–2030) |
9. |
Spasticity Treatments and Medical Practices |
10. |
Spasticity Marketed Therapies |
11. |
Spasticity Emerging Therapies |
12. |
Spasticity Market Size |
13. |
7MM: Country-wise Market Analysis |
14. |
Spasticity Market Drivers |
15. |
Spasticity Market Barriers |
16. |
SWOT Analysis |
17. |
KOL Views |
18. |
Reimbursement and market access |
19. |
Report Methodology |
20. |
DelveInsight Capabilities |
21. |
Disclaimer |
22. |
About DelveInsight |
About DelveInsight
DelveInsight is a leading Business Consultant and Market
Research firm focused exclusively on life sciences. It supports Pharma
companies by providing end to end comprehensive solutions to improve their
performance.
Spasticity market,Spasticity market trends,Spasticity market
forecast,Spasticity market share,Spasticity pipeline,Spasticity treatment
algorithm,Spasticity drugs,Spasticity market size,Spasticity CAGR,Spasticity
epidemiology
Comments
Post a Comment